Li H, Su H B, Wang Y G, Yan L L, Peng Y H, Li C, Liu X Y, Hu J H, Ning P, Guan C D
Department of Hepatology Medicine, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Department of Critical Care Medicine, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Zhonghua Gan Zang Bing Za Zhi. 2023 Mar 20;31(3):300-306. doi: 10.3760/cma.j.cn501113-20230224-00077.
To explore the predictive value of lactic acid for the adverse prognostic outcomes in patients with acute-on-chronic liver failure combined with infection. A retrospective analysis was conducted on the clinical data of 208 cases of ACLF combined with infection who were hospitalized from January 2014 to March 2016. Patients were divided into a survival group ( = 83) and a mortality group ( = 125) according to the results of a 90-day follow-up. The clinical data were statistically analyzed between the two groups. Multivariate logistic regression with two categorical variables was used to analyze the independent risk factors for 90-day disease mortality and establish a new prediction model. The receiver operating characteristic curve (ROC curve) was used to evaluate the predictive value of lactic acid, the MELD score, the MELD-Na score, lactic acid combined with the MELD score, lactic acid combined with the MELD-Na score, and the new model. The 90-day mortality rate of 208 cases of ACLF combined with infection was 60.1%. There were statistically significant differences in white blood cell count, neutrophil count, total bilirubin (TBil), serum creatinine (Cr), blood urea nitrogen (BUN), blood ammonia, the international normalized ratio (INR), lactic acid (LAC), procalcitonin, the MELD score, the MELD-Na score, hepatic encephalopathy (HE), acute kidney injury (AKI), and bleeding between the two groups. Multivariate logistic regression analysis showed that TBil, INR, LAC, HE, and bleeding were independent risk factors for 90-day mortality in patients with ACLF combined with infection. After the establishment of MELD-LAC, MELD-Na-LAC, and a new prediction model, the ROC curve revealed that the AUC (95% confidence interval) of MELD-LAC and MELD-Na LAC were 0.819 (0.759 ~ 0.870) and 0.838 (0.780 ~ 0.886), respectively, and was superior than the MELD score [0.766 (0.702 ~ 0.823)] and MELD-Na score [0.788 (0.726 ~ 0.843)], with < 0.05, while the new model had an AUC of 0.924, the sensitivity of 83.9%, specificity of 89.9%, and accuracy of 87.8%, which was higher than LAC, MELD score, MELD-Na score, MELD-LAC, and MELD-Na-LAC ( < 0.01). Lactic acid is an independent risk factor for mortality in patients with ACLF combined with infection, and it improves the clinical predictive value of MELD and MELD-Na for the prognosis of mortality.
探讨乳酸对慢性肝衰竭急性发作合并感染患者不良预后结局的预测价值。对2014年1月至2016年3月住院的208例慢性肝衰竭急性发作合并感染患者的临床资料进行回顾性分析。根据90天随访结果将患者分为生存组(n = 83)和死亡组(n = 125)。对两组临床资料进行统计学分析。采用具有两个分类变量的多因素logistic回归分析90天疾病死亡的独立危险因素并建立新的预测模型。采用受试者工作特征曲线(ROC曲线)评估乳酸、终末期肝病模型(MELD)评分、MELD-Na评分、乳酸联合MELD评分、乳酸联合MELD-Na评分及新模型的预测价值。208例慢性肝衰竭急性发作合并感染患者的90天死亡率为60.1%。两组在白细胞计数、中性粒细胞计数、总胆红素(TBil)、血清肌酐(Cr)、血尿素氮(BUN)、血氨、国际标准化比值(INR)、乳酸(LAC)、降钙素原、MELD评分、MELD-Na评分、肝性脑病(HE)、急性肾损伤(AKI)及出血方面差异有统计学意义。多因素logistic回归分析显示,TBil、INR、LAC、HE及出血是慢性肝衰竭急性发作合并感染患者90天死亡的独立危险因素。建立MELD-LAC、MELD-Na-LAC及新预测模型后,ROC曲线显示MELD-LAC和MELD-Na-LAC的曲线下面积(AUC,95%可信区间)分别为0.819(0.7590.870)和0.838(0.7800.886),优于MELD评分[0.766(0.7020.823)]和MELD-Na评分[0.788(0.7260.843)],P<0.05,而新模型的AUC为0.924,敏感度为83.9%,特异度为89.9%,准确度为87.8%,高于LAC、MELD评分、MELD-Na评分、MELD-LAC及MELD-Na-LAC(P<0.01)。乳酸是慢性肝衰竭急性发作合并感染患者死亡的独立危险因素,且提高了MELD和MELD-Na对死亡预后的临床预测价值。